EEF1A1P44: A Drug Target / Disease Biomarker (G100421840)

Target Name: EEF1A1P44

NCBI ID: G100421840

EEF1A1P44

Other Name(s): Eukaryotic translation elongation factor 1 alpha 2 pseudogene | eukaryotic translation elongation factor 1 alpha 1 pseudogene 44 | LOC100421840

EEF1A1P44: A Drug Target / Disease Biomarker

EEF1A1P44 is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. Its full name is estimon, which is a type of RNA-protein hybrid that is derived from the encoded gene EEF1A1P44.

The protein encoded by EEF1A1P44 is a 21-kDa protein that contains 116 amino acid residues. It is composed of a cytoplasmic tail, a transmembrane region, and an N-terminus. The cytoplasmic tail of the protein is the region that is involved in the protein's stability and functions as a scaffold. The transmembrane region is the region that spans the cell membrane and is involved in the protein's localization and interactions with other cellular components. The N-terminus is the region that interacts with other proteins and molecules.

One of the key functions of EEF1A1P44 is its role in the regulation of cell growth and differentiation. The protein is involved in the negative regulation of cell proliferation, which is the process by which cells grow and divide. This is achieved through its ability to interact with and inhibit the activity of the transcription factor, p53.

In addition to its role in cell growth and differentiation, EEF1A1P44 is also involved in the regulation of cell survival. The protein is involved in the negative regulation of apoptosis, which is the process by which cells die and are removed from the body. This is achieved through its ability to interact with and inhibit the activity of the caspase-7, a protein that is involved in apoptosis.

The protein encoded by EEF1A1P44 has also been shown to be involved in the regulation of inflammation. The protein is involved in the regulation of the immune response, specifically in the regulation of T cell development and function. This is achieved through its ability to interact with and inhibit the activity of the transcription factor, NF-kappa-B.

In conclusion, EEF1A1P44 is a protein that is involved in a variety of cellular processes, including cell growth and differentiation, cell survival, and inflammation. As a result, it is a potential drug target and a biomarker for a variety of diseases. Further research is needed to fully understand the functions of EEF1A1P44 and its potential as a therapeutic agent.

Protein Name: Eukaryotic Translation Elongation Factor 1 Alpha 1 Pseudogene 44

The "EEF1A1P44 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EEF1A1P44 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets